Find new cures in approved drugs.
LatentRx Therapeutics builds computational tools that mine disease signals, model protein targets, and virtually screen thousands of approved compounds — surfacing repurposing candidates for neglected diseases faster than traditional pipelines.
Five stages. One workspace.
Every stage is deterministic, versioned, and inspectable. Operators confirm each hand-off before compute time is spent.
Curated databases scanned for essential biological pathways and druggable vulnerabilities.
Signals mapped to specific proteins with active-site annotations and structural data.
3D protein structures built from templates with quality scoring and pocket detection.
Approved drug libraries screened against targets using physics-based binding simulations.
Multi-factor scoring — affinity, selectivity, ADMET — to surface the most promising hits.
Ready to repurpose?
LatentDx screens 12,400+ approved drugs against your disease targets. Sign in to start building campaigns.